NPR logo

FDA Approves Embryonic Stem Cell Trial In Humans

  • Download
  • <iframe src="https://www.npr.org/player/embed/99800012/99800004" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript
FDA Approves Embryonic Stem Cell Trial In Humans

Health

FDA Approves Embryonic Stem Cell Trial In Humans

FDA Approves Embryonic Stem Cell Trial In Humans

  • Download
  • <iframe src="https://www.npr.org/player/embed/99800012/99800004" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Biotech company Geron Corp. will conduct a human clinical trial on patients with spinal cord injuries, using a federally approved line of embryonic stem cells. The approval is the first of its kind in the world. Stem cell experts discuss the significance of the decision.

Guests:

Thomas Okarma, president and CEO, Geron Corporation, Menlo Park, Calif.

Sean J. Morrison, director, University of Michigan Center for Stem Cell Biology, Ann Arbor, Mich.